Jefferies Releases a Buy Rating on Magellan Health

In a report released yesterday, David Styblo from Jefferies reiterated a Buy rating on Magellan Health (NASDAQ: MGLN), with a price target of $88. The company’s shares closed yesterday at $74.35. According More »

Canaccord Genuity Releases a Buy Rating on Evolent Health

In a report released yesterday, Richard Close from Canaccord Genuity reiterated a Buy rating on Evolent Health (NYSE: EVH), with a price target of $31. The company’s shares closed yesterday at $20.35. More »